Kathryn Edwards
Pediatric Infectious Diseases · Nashville, TNNPI 1104918523
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $293,220 of the $332,289 with a category attached, or 88.2%. 15 manufacturers reported payments, led by Pfizer at 32.2% of the total. 2025 is the largest year on record at $68,979, 10.0 times the $6,930 reported in 2019. Among pediatric infectious diseases clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 200 payments — averaging $1661.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$107K
- Merck$56K
- Modernatx, Inc.$51K
- AstraZeneca$36K
- GSK$23K
- Dynavax Technologies Corporation$13K
- plus $46K from 9 others
Across 31 payments — averaging $1229.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seqirus USA Inc$21K
- Modernatx, Inc.$9K
- Sanofi Pasteur Inc.$7K
- Bavarian Nordic A/s$1K
What the payments were for
- Consulting fees$293,22088%
- Speaking & faculty fees$11,9034%
- Travel & lodging$25,9328%
- Food & beverage$1,2340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 39 | $106,971 |
| Merck | 74 | $55,914 |
| Modernatx, Inc. | 32 | $50,731 |
| AstraZeneca | 15 | $36,291 |
| GSK | 8 | $22,628 |
| Dynavax Technologies Corporation | 7 | $13,484 |
| Sanofi Pasteur Inc. | 9 | $12,506 |
| Eli Lilly | 1 | $6,525 |
| Seqirus USA Inc | 4 | $6,000 |
| Janssen Research & Development, LLC | 1 | $5,980 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $5,060 |
| F. Hoffmann-la Roche AG | 4 | $4,790 |
| Novavax Inc | 3 | $2,500 |
| Orphai Therapeutics Inc. | 1 | $2,000 |
| Astrazeneca UK Limited | 1 | $910 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$332,289 in reported general payments places this provider in the 90th percentile of 36 pediatric infectious diseases providers in Tennessee.
See all pediatric infectious diseases providers in Tennessee →
Other pediatric infectious diseases in Nashville
- Clarence CreechNashville$98K
- James CroweNashville$94K
- Isaac ThomsenNashville$13K
- Daniel DulekNashville$5K
- Natasha HalasaNashville$5K
- Sophie KatzNashville$5K
- Mark DenisonNashville$3K
- Christopher KeeferNashville$348
- Anthony FloresNashville$298
- Ritu BanerjeeNashville$230
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.